Overview

A Study Comparing the Efficacy of TA103 and the Placebo Control in the Treatment of Interdigital Tinea Pedis.

Status:
Completed
Trial end date:
2021-02-20
Target enrollment:
Participant gender:
Summary
To evaluate and compare the safety and efficacy of TA103 in the treatment of tinea pedis.
Phase:
Early Phase 1
Details
Lead Sponsor:
Taro Pharmaceuticals USA